A practical model for controlling lawful supply, destination requirements, exporter authority, counterparties, shipment execution, exceptions and governance.
Every export should leave a traceable chain from the real transaction and destination requirements through authority, party and product checks to controlled dispatch, exception handling and governance follow-up.
Define the commercial and physical transaction, destination conditions and the permissions required before supply.
Verify exporter authority, counterparties, product eligibility, permits and documentary evidence against the actual route.
Control shipment approval, security, temperature, custody, receipt and any exception or disposition decision.
Review route performance, expiring permissions, recurring failures, actions and effectiveness across the export portfolio.
Use the complete workspace, supporting guide and linked tools to structure export assessment, execution and evidence.
This model supports human-medicines export assessment. Record origin, destination and transit jurisdictions, including any Great Britain or Northern Ireland differences. Import assurance remains in the RP-I model; unlicensed-medicines supply needs its own assessment.
Sources checked 21 September 2026. Inspector blogs explain practical expectations at their publication date. Industry commentary is supporting reading. Use current official guidance and destination evidence for each decision. Worked scenarios are illustrative RegOpsPro examples.
View the export source coverage register for scope, dates and knowledge-search availability.
Support is available for route mapping, licence-boundary review, counterparty controls, governance design and implementation of the operating model. You can use the operating model and guide independently of consulting support.
RegOpsPro™